POINT BIOPHARMA GLOBAL
PNT Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2023-12-27
2023-12-27
MCCANN JOE
Chief Executive Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-1.07M
2
$904.65M
2023-12-27
2023-12-27
SILBER ALLAN
Executive Chairman
D - Sale to Issuer
Stock Option (Right to Buy)
-877K
3
$904.65M
2023-12-27
2023-12-27
KELLY JUSTYNA
Chief Operating Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-278K
5
$904.65M
2023-12-27
2023-12-27
LUBNER DAVID CHARLES
D - Sale to Issuer
Stock Option (Right to Buy)
-95,363
3
$904.65M
2023-12-27
2023-12-27
DEMERS WILLIAM
Chief Financial Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-433K
4
$904.65M
2023-12-27
2023-12-27
FLESHNER NEIL
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-169K
3
$904.65M
2023-12-27
2023-12-27
JENSEN JESSICA
EVP Clinical Development
D - Sale to Issuer
Stock Option (Right to Buy)
-950K
5
$904.65M
2023-12-18
2023-12-20
BVF PARTNERS P/IL
S - Sale
Common Stock, $0.0001 par value
-17M
$12.45
-214M
3
$904.65M
2023-03-28
2023-03-30
FLESHNER NEIL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
84,257
$0.00
1
$904.65M
2023-03-28
2023-03-30
SILBER ALLAN
Executive Chairman
A - Grant
Stock Option (Right to Buy)
537K
$0.00
1
$904.65M
2023-03-28
2023-03-30
DEMERS WILLIAM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
131K
$0.00
1
$904.65M
2023-03-28
2023-03-30
JENSEN JESSICA
EVP Clinical Development
A - Grant
Stock Option (Right to Buy)
136K
$0.00
1
$904.65M
2023-03-28
2023-03-30
KELLY JUSTYNA
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
98,358
$0.00
1
$904.65M
2023-03-28
2023-03-30
MCCANN JOE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
693K
$0.00
1
$904.65M
2022-11-29
2022-11-30
MCCANN JOE
Chief Executive Officer
P - Purchase
Common Stock
2,160
$7.00
15,120
1
$904.65M
2022-11-18
2022-11-21
SILBER ALLAN
Executive Chairman
P - Purchase
Common Stock
22,397
$7.00
157K
1
$904.65M
2022-11-17
2022-11-21
SILBER ALLAN
Executive Chairman
P - Purchase
Common Stock
27,603
$6.00
166K
1
$904.65M
2022-05-25
2022-05-26
FLESHNER NEIL
Chief Medical Officer
S - Sale
Common Stock
-564K
$8.00
-4.51M
1
$904.65M
2022-04-01
2022-04-05
JENSEN JESSICA
EVP Clinical Development
A - Grant
Stock Option (Right to Buy)
13,766
$0.00
1
$904.65M
2022-03-29
2022-03-31
DEMERS WILLIAM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
105K
$0.00
1
$904.65M
2022-03-29
2022-03-31
FLESHNER NEIL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
60,234
$0.00
1
$904.65M
2022-03-29
2022-03-31
JENSEN JESSICA
EVP Clinical Development
A - Grant
Stock Option (Right to Buy)
213K
$0.00
1
$904.65M
2022-03-29
2022-03-31
KELLY JUSTYNA
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
77,958
$0.00
1
$904.65M
2022-03-29
2022-03-31
MCCANN JOE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
382K
$0.00
1
$904.65M
2022-03-29
2022-03-31
SILBER ALLAN
Executive Chairman
A - Grant
Stock Option (Right to Buy)
332K
$0.00
1
$904.65M
2021-12-09
2021-12-10
KELLY JUSTYNA
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$904.65M
2021-07-06
2021-07-08
DEMERS WILLIAM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
16,767
$0.00
1
$904.65M
2021-07-06
2021-07-08
FLESHNER NEIL
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
25,000
$0.00
1
$904.65M
2021-07-06
2021-07-08
GOTTLIEB MICHAEL
Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
48,000
$0.00
1
$904.65M
2021-07-06
2021-07-08
JENSEN JESSICA
EVP Clinical Development
A - Grant
Stock Option (Right to Buy)
461K
$0.00
1
$904.65M
2021-06-30
2021-06-30
DEMERS WILLIAM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
179K
$0.00
1
$904.65M
2021-06-30
2021-06-30
JENSEN JESSICA
EVP Clinical Development
A - Grant
Stock Option (Right to Buy)
126K
$0.00
1
$904.65M